Atlas FDA

cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for

FDA device recall Z-0489-2025 · posted 2024-11-19 · Open, Classified

Recall details

Recalling firm
Roche Diagnostics Operations, Inc.
Reason for recall
Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
Action taken
Roche issued an URGENT MEDICAL DEVICE CORRECTION notice to its consignees on 10/17/2024 via UPS Ground. The notice explained the issue, clinical significance, and requested the following actions be taken: "" HCYS kits lot number 747029 expired on September 30, 2024. Ensure any inventory you have of this lot has been discarded per your local guidelines. " Follow your laboratory s standard operating procedures to determine specific clinical implications for your patients and whether retrospective review of patient results is required. " Consult with the physician or pathologist at your facility to determine specific clinical implications for your patients. " If your facility has distributed the affected product to another site, please ensure this UMDC is provided to that site." For questions: contact the Roche Support Network Customer Support Center, 24 hours a day, seven days a week at 1-800-428-2336
Root cause
Under Investigation by firm
Status
Open, Classified
Product code
LPS
Quantity affected
458 units
Distribution
US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,
Date initiated
2024-10-17
Date posted
2024-11-19
Location
Indianapolis, IN

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
HOMOCYSTEINE TEST (K113793)Roche2012-06-05